Hongcheng Innovation Secures Nearly RMB 100 Million in Series A+ Funding Led by Youshan Capital

VCBeat (WeChat: vcbeat) has learned that Beijing HC-Innovation Tech Co., Ltd. (“HC-Innovation”), a trusted management service provider for biological resources, has successfully completed its Series A+ financing round of nearly RMB 100 million, led by Youshan Capital.

Beijing HC-Innovation Tech Co., Ltd. was established on May 4, 2014. As a high-tech enterprise specializing in the security management of biological resources, it is widely recognized within the industry as a leading provider of trusted biological resource management services. The company was founded by Mr. Tian Chuan, and its core team primarily consists of alumni from Tsinghua University and the Chinese Academy of Sciences.

In the field of biological resource management and utilization, traditional barcode-based information management systems suffer from inherent weaknesses, including heavy reliance on manual operations and high workloads. These limitations often lead to human errors, compromised sample quality, discrepancies between inventory records and physical stock, and difficulties in information traceability, potentially resulting in major biosafety incidents such as sample misidentification, omissions, or loss. There is an urgent industry need for highly refined, independently controllable innovative solutions that integrate the Internet of Things (IoT), artificial intelligence (AI), and big data to intelligently upgrade existing management practices and eliminate biosafety risks. However, biological resource management involves unique scenarios characterized by liquid samples stored in low-temperature and ultra-low-temperature environments, where conventional IoT sensing technologies fail to operate effectively. To successfully deploy next-generation information technologies like IoT in this domain, the international challenge of wireless sensing in ultra-low-temperature environments must first be addressed, enabling the assignment of unique chip identifiers to individual samples and their integration into the IoT ecosystem.

Leveraging years of accumulated R&D expertise in hard technology, Beijing HC-Innovation Tech Co., Ltd. has developed the “Trusted Biological Resource Management Platform.” By addressing the challenge of “non-contact sensing in ultra-low temperature environments” and deeply integrating IoT, blockchain, and big data technologies, this platform represents China’s first and only solution to achieve automated, refined, and intelligent full-process, full-category, and full-temperature-range safety monitoring at the individual item level for biological resources such as bacterial/viral strains, blood, and stem cells. It provides a one-stop trusted management solution featuring efficient data acquisition, transparent business processing, and intelligent decision-making support, thereby facilitating the implementation of national biosafety strategies. Currently, the “Trusted Biological Resource Management Platform” series has been deployed and applied at biological resource regulatory and service institutions—including the Chinese Center for Disease Control and Prevention, the Military Blood Collection and Supply Center, the Anhui Provincial Blood Center, the Suzhou Central Blood Station, and Beijing Hospital—as well as at leading enterprises involved in biological resource management, such as Joinn Laboratories. These implementations have yielded significant social and economic benefits.

Youshan Capital believes that the 21st century is the century of biology, and biosafety is integral to national security. Youshan Capital remains bullish on the intelligent upgrading of existing biological resource management through next-generation information technologies such as the Internet of Things (IoT), viewing this sector as holding significant promise. Beijing HC-Innovation Tech Co., Ltd. is a leading domestic provider of trusted biological resource management services. The company’s strong hard-tech attributes, comprehensive product portfolio, and robust execution capabilities are deeply impressive. Founder Mr. Tian Chuan has demonstrated remarkable strategic focus, leading the company in “a decade of honing a single sword” to overcome fundamental technological challenges. By deeply integrating into user scenarios, the company has refined its “Trusted Biological Resource Management Platform,” which has been deployed by dozens of benchmark clients, including the Chinese Center for Disease Control and Prevention. We look forward to HC-Innovation, under Mr. Tian Chuan’s leadership, building a great enterprise through groundbreaking innovation, giving back to the nation and society with technology, and contributing to China’s biosafety.

Tian Chuan, Chairman of HC-Innovation

Youshan Capital was founded in 2019 by Ms. Chen Shiyou, the founder of the former investment platform at China International Capital Corporation (CICC). Its inaugural flagship direct investment fund has a size of approximately RMB 3.3 billion, with investors consisting entirely of large-scale institutions, including central state-owned enterprises, listed companies, and market-oriented fund-of-funds, among other renowned professional institutions. Youshan Capital focuses on investing in high-growth enterprises in technology-enabled industries such as TMT, healthcare, and advanced manufacturing. The team possesses keen insights into frontier technological developments, expert support, and industrial synergy capabilities, creating value for portfolio companies across multiple dimensions, including market expansion, talent acquisition, strategic planning, and capital operations.